BRIEF published on 11/12/2024 at 07:35, 9 days 6 hours ago ElringKlinger Reports Solid Q3 2024 Results Amidst Challenges Revenue Growth Financial Performance ElringKlinger AG Q3 2024 Results Strategic Divestments
PRESS RELEASE published on 11/12/2024 at 07:30, 9 days 6 hours ago Q3 2024: ElringKlinger records solid results amid difficult conditions ElringKlinger AG reports solid Q3 2024 results with EUR 441 million revenue amid challenging backdrop. Adjusted EBIT margin at 5.2% Financial Results Revenue Adjusted EBIT Margin Q3 2024 ElringKlinger AG
BRIEF published on 10/07/2024 at 13:23, 1 month 14 days ago ElringKlinger Refines Focus by Selling Two Subsidiaries Automotive Industry Strategic Realignment ElringKlinger Subsidiary Sale Certina Group
PRESS RELEASE published on 10/07/2024 at 13:18, 1 month 14 days ago ElringKlinger hones its corporate profile and disposes of two Group companies ElringKlinger hones corporate profile, sells two Group companies to Certina Group as part of strategic decision to focus on thermal and acoustic shielding products Strategic Decision Divestment ElringKlinger Certina Group Thermal Shielding
BRIEF published on 10/07/2024 at 12:52, 1 month 14 days ago ElringKlinger AG Faces Non-Cash Losses Due to Sale of Group Companies Automotive Industry Impairment Losses ElringKlinger AG 2024 Financial Guidance Group Sale
PRESS RELEASE published on 10/07/2024 at 12:47, 1 month 14 days ago EQS-Adhoc: ElringKlinger AG: Non-cash impairment losses relating to the sale of two Group companies and adjustment to the annual guidance ElringKlinger AG announces non-cash impairment losses from sale of two Group companies and adjusts annual guidance amidst industry transformations Automotive Industry Impairment Losses ElringKlinger AG Annual Guidance Certina Group
BRIEF published on 08/07/2024 at 07:44, 3 months 14 days ago ElringKlinger Records Solid Second-Quarter Performance in 2024 EBITDA Financial Performance Revenue Automotive Market SHAPE30 Strategy
PRESS RELEASE published on 08/07/2024 at 07:39, 3 months 14 days ago ElringKlinger records solid second-quarter performance in 2024 ElringKlinger reports solid second-quarter performance in 2024 with EUR 445.0 million revenue, 5.0% adjusted EBIT margin, and progress on SHAPE30 transformation strategy Revenue 2024 ElringKlinger SHAPE30 Second-quarter Performance
BRIEF published on 06/25/2024 at 11:10, 4 months 26 days ago ElringKlinger to Open New Battery Center in the USA South Carolina E-mobility ElringKlinger Battery Center SHAPE30
PRESS RELEASE published on 06/25/2024 at 11:05, 4 months 26 days ago ElringKlinger to open new Battery Center in the USA ElringKlinger AG announces the opening of a new Battery Center in the USA, focusing on manufacturing battery technology products for the American market Manufacturing E-mobility ElringKlinger AG USA Battery Center
Published on 11/21/2024 at 13:30, 17 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 17 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 47 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 47 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 47 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 12 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 32 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 49 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 27 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 2 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
